Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Liver Cancer”

865 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 865 results

Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT00384800
What this trial is testing

A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Far Eastern Memorial Hospital 41
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Testing effectiveness (Phase 2)UnknownNCT05774964
What this trial is testing

Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

Who this might be right for
For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
Liaoning Cancer Hospital & Institute 100
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Not applicableActive Not RecruitingNCT06579833
What this trial is testing

Histotripsy (HistoSonics®) for Liver Tumours

Who this might be right for
Liver Tumour
The University of Hong Kong 60
Not applicableLooking for participantsNCT05150145
What this trial is testing

Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer

Who this might be right for
Radiotherapy; Complications
Guizhou Medical University 66
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05485909
What this trial is testing

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Who this might be right for
Colorectal Cancer Liver Metastases
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Study completedNCT01204177
What this trial is testing

Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.

Who this might be right for
Carcinoma, Hepatocellular
Bayer 70
Testing effectiveness (Phase 2)Looking for participantsNCT06953089
What this trial is testing

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors
DualityBio Inc. 492
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Testing effectiveness (Phase 2)Study completedNCT00943449
What this trial is testing

4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
4SC AG 57
Testing effectiveness (Phase 2)Looking for participantsNCT07324304
What this trial is testing

NWRD06 DNA Plasmid for HCC After Curative Resection.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Newish Technology (Beijing) Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT05134532
What this trial is testing

Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
CHA University 40
Testing effectiveness (Phase 2)Ended earlyNCT01464593
What this trial is testing

Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)

Who this might be right for
Colon Cancer Liver Metastasis
Imunon 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06193733
What this trial is testing

Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Chang Gung Memorial Hospital 74
Testing effectiveness (Phase 2)UnknownNCT00054951
What this trial is testing

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Who this might be right for
Hepatocellular Carcinoma
FeRx 30
Load More Results